Research Topics
Species | C S CleelandSummaryAffiliation: The University of Texas Country: USA Publications
Research Grants
| Collaborators
|
Detail Information
Publications
Pain outcomes in patients with advanced breast cancer and bone metastases: Results from a randomized, double-blind study of denosumab and zoledronic acidCharles S Cleeland
University of Texas, MD Anderson Cancer Center, Department of Symptom Research, Houston, Texas
Cancer 119:832-8. 2013..In this study, the authors evaluated the effect of denosumab versus zoledronic acid (ZA) on pain in patients with advanced breast cancer and bone metastases...
Recommendations for including multiple symptoms as endpoints in cancer clinical trials: a report from the ASCPRO (Assessing the Symptoms of Cancer Using Patient-Reported Outcomes) Multisymptom Task ForceCharles S Cleeland
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 119:411-20. 2013..A representation of changes in multiple symptoms would clarify the impact of treatment and enhance the interpretation of cancer clinical trials for clinicians, patients, and those who make health care policy...
Reducing the toxicity of cancer therapy: recognizing needs, taking actionCharles S Cleeland
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, TX 77030, USA
Nat Rev Clin Oncol 9:471-8. 2012..With an emphasis on coordinating multidisciplinary efforts, this panel has presented a strategy to increase funding for the field and develop a coherent research agenda...
Cancer pain management by radiotherapists: a survey of radiation therapy oncology group physiciansC S Cleeland
Pain Research Group, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 47:203-8. 2000..Radiation Therapy Oncology Group (RTOG) physicians were surveyed to determine their approach to and attitudes toward cancer pain management...
Levels of symptom burden during chemotherapy for advanced lung cancer: differences between public hospitals and a tertiary cancer centerCharles S Cleeland
The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 29:2859-65. 2011..We compared risk factors for high disease- and treatment-related symptom burden over 15 weeks of therapy in medically underserved patients with advanced non-small-cell lung cancer and in patients treated at a tertiary cancer center...
Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptomsCharles S Cleeland
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Cancer 97:2919-25. 2003..These symptoms include pain, wasting, fatigue, cognitive impairment, anxiety, and depression, many of which co-occur. There is growing recognition that at least some of these symptoms may share common biologic mechanisms...
The measurement of pain from metastatic bone disease: capturing the patient's experienceCharles S Cleeland
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 12:6236s-6242s. 2006..These and other considerations in the design of clinical trials are discussed...
Rapid improvement in pain management: the Veterans Health Administration and the institute for healthcare improvement collaborativeCharles S Cleeland
Pain Research Group, Department of Symptom Research, U T M D Anderson Cancer Center, Houston, Texas, USA
Clin J Pain 19:298-305. 2003..With the goal of rapid improvement in pain management, a joint Collaborative (Veterans Health Administration and Institute for Healthcare Improvement) was conducted from May 2000 to January 2001...
Does an oral analgesic protocol improve pain control for patients with cancer? An intergroup study coordinated by the Eastern Cooperative Oncology GroupC S Cleeland
The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Ann Oncol 16:972-80. 2005..Cancer pain is highly prevalent and commonly undertreated. This study was designed to determine whether dissemination of a clinical protocol for pain management would improve outcomes in community oncology practices...
Automated symptom alerts reduce postoperative symptom severity after cancer surgery: a randomized controlled clinical trialCharles S Cleeland
The University of Texas MD Anderson Cancer Center, Department of Symptom Research, 1515 Holcombe Blvd, Box 1450, Houston, TX 77030, USA
J Clin Oncol 29:994-1000. 2011..This study examined whether at-home symptom monitoring plus feedback to clinicians about severe symptoms contributes to more effective postoperative symptom control...
Pain assessment: the advantages of using pain scales in lysosomal storage diseasesC S Cleeland
Department of Symptom Research, Division of Anesthesiology and Critical Care, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Acta Paediatr Suppl 91:43-7. 2002..In Fabry disease, these should be used routinely to aid decisions concerning analgesic/pain control medication and to assess the effect of enzyme replacement therapy...
Integrating pain metrics into oncology clinical trialsCharles S Cleeland
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
Clin Cancer Res 17:6646-50. 2011..A number of methodologic and logistical challenges that hinder the ability to assess pain response in clinical trials are discussed in this article. Possible ways to address these challenges are also discussed...
Assessing symptom distress in cancer patients: the M.D. Anderson Symptom InventoryC S Cleeland
Pain Research Group, Division of Anesthesiology and Critical Care, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 89:1634-46. 2000..The purpose of this project was to develop the M. D. Anderson Symptom Inventory (MDASI), a brief measure of the severity and impact of cancer-related symptoms...
When is it justified to treat symptoms? Measuring symptom burdenCharles S Cleeland
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Oncology (Williston Park) 16:64-70. 2002..Finally, we discuss potential research challenges and offer recommendations on future research directions...
End-of-life care in urban areas of China: a survey of 60 oncology cliniciansXin Shelley Wang
Department of Symptom Research, World Health Organization's Collaborating Center on Supportive Cancer Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 27:125-32. 2004..Results of the survey suggest specific training and research in symptom management that might improve end-of-life care for Chinese cancer patients...
Adequacy of cancer pain management in a Japanese Cancer HospitalToru Okuyama
Department of Symptom Research, Division of Anesthesiology and Critical Care, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
Jpn J Clin Oncol 34:37-42. 2004..Remedial action should be taken, including increasing awareness of symptom management in medical staff and incorporating existing knowledge into routine clinical practice...
A fatigue clinic in a comprehensive cancer center: design and experiencesC P Escalante
Department of General Internal Medicine, Ambulatory Treatment and Emergency Care, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 92:1708-13. 2001..This article describes the general clinic design and operations and the preliminary analysis of the first 40 patients evaluated in the fatigue clinic...
Temporal patterns of fatigue predict pathologic response in patients treated with preoperative chemoradiation therapy for rectal cancerHee Chul Park
Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030 4009, USA
Int J Radiat Oncol Biol Phys 75:775-81. 2009..To investigate whether symptom burden before and during preoperative chemoradiation therapy (CRT) for rectal cancer predicts for pathologic tumor response...
Validation study of the Chinese version of the Brief Fatigue Inventory (BFI-C)Xin Shelley Wang
Department of Symptom Research, Division of Anesthesiology and Critical Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 27:322-32. 2004..The BFI-C is a valid, reliable instrument to measure the severity and impact of cancer-related fatigue among Chinese patients...
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositisDavid I Rosenthal
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
Int J Radiat Oncol Biol Phys 72:1355-61. 2008....
Fatigue during preoperative chemoradiation for resectable rectal cancerX S Wang
Pain Research Group, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 92:1725-32. 2001..Based on identified predictors for fatigue, more active pain management before CXT/XRT and bowel management during CTX/XRT might reduce cancer-related fatigue in these patients...
Symptom burden in patients undergoing autologous stem-cell transplantationK O Anderson
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Bone Marrow Transplant 39:759-66. 2007..The patterns of fatigue, pain, sleep disturbance and lack of appetite were significantly different for patients with multiple myeloma as compared with patients with non-Hodgkin's lymphoma...
Health care providers' assessments of the quality of advanced-cancer care in Latin American medical institutions: a comparison of predictors in five countries: Argentina, Brazil, Cuba, Mexico, and PeruIsabel Torres-Vigil
Department of Health Disparities Research, Center for Research on Minority Health at The University of Texas M D Anderson Cancer Center, Houston, TX 77021, USA
J Pain Palliat Care Pharmacother 22:7-20. 2008....
Asking the community about cutpoints used to describe mild, moderate, and severe painGuadalupe R Palos
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, 77030, USA
J Pain 7:49-56. 2006..Having standard categories to describe pain severity might increase clinicians' confidence in using a numeric scale to make treatment decisions. Further studies of cutpoint methodology and its clinical importance are warranted...
Serum interleukin-6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantationXin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 113:2102-9. 2008..However, the mechanism underlying the development of multiple symptoms has not been established...
Assessing persistent cancer pain: a comparison of current pain ratings and pain recalled from the past weekQiuling Shi
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 37:168-74. 2009..Our results provide information that might guide the choice of recall period for cancer clinical trials with pain as a self-reported outcome...
Brief cognitive-behavioral audiotape interventions for cancer-related pain: Immediate but not long-term effectivenessKaren O Anderson
Department of Symptom Research, Division of Internal Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 107:207-14. 2006..A randomized clinical trial was performed evaluating the efficacy of 3 brief cognitive-behavioral techniques: relaxation, distraction, and positive mood interventions...
The association between symptom burdens and utility in Chinese cancer patientsYa Chen Tina Shih
Section of Health Services Research, Department of Biostatistics and Applied Mathematics, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
Qual Life Res 15:1427-38. 2006..This study explored the relationship between the M. D. Anderson Symptom Inventory (MDASI), an instrument measuring the severity of symptoms common to patients with cancer, and utility derived from the SF-36...
Filipino version of the M. D. Anderson Symptom Inventory: validation and multisymptom measurement in cancer patientsXin Shelley Wang
Department of Symptom Research X S W, H G, T R M, C S C, Division of Internal Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 31:542-52. 2006..Cancer patients reported significantly greater symptom severity on multiple items than did the community sample. The MDASI-F is reliable and valid for evaluating cancer-related symptoms and their impact on Filipino cancer patients...
An urban community's preferences for hypothetical outcomes of analgesic pain treatmentGuadalupe R Palos
Department of Symptom Research, University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
J Pain Symptom Manage 32:470-7. 2006..Knowledge of public preferences can help clinicians better understand factors that influence treatment choices and may help them motivate their patients to adhere to analgesic regimens...
What predicts the quality of advanced cancer care in Latin America? A look at five countries: Argentina, Brazil, Cuba, Mexico, and PeruIsabel Torres Vigil
Center for Research on Minority Health, Department of Health Disparities Research, University of Texas M D Anderson Cancer Center, Houston, Texas 77021, USA
J Pain Symptom Manage 34:315-27. 2007....
Pain, depression, and fatigue in community-dwelling adults with and without a history of cancerCielito C Reyes-Gibby
Department of Epidemiology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77230 1439, USA
J Pain Symptom Manage 32:118-28. 2006..21; 95%CI = 1.06,1.37), and pain (OR = 1.15; 95%CI = 1.03,1.28). Symptom clusters were also more prevalent among those with a history of cancer (P < 0.001), with the pain-depression-fatigue cluster as most prevalent...
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck moduleDavid I Rosenthal
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
Head Neck 29:923-31. 2007....
Pain in aging community-dwelling adults in the United States: non-Hispanic whites, non-Hispanic blacks, and HispanicsCielito C Reyes-Gibby
Department of Epidemiology, UT MD Anderson Cancer Center, Houston, TX 77030 4009, USA
J Pain 8:75-84. 2007..S. can be accounted for by differential vulnerability in terms of chronic disease, socioeconomic conditions, and access to care...
Longitudinal study of the relationship between chemoradiation therapy for non-small-cell lung cancer and patient symptomsXin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 24:4485-91. 2006....
Symptom burden in cancer survivorshipV Shannon Burkett
The Department of Symptom Research, The University of Texas M D Anderson Cancer Center, 1100 Holcombe Blvd, Unit 221, Houston, TX 77030, USA
J Cancer Surviv 1:167-75. 2007..This paper contrasts symptom burden with general HRQOL and addresses the importance of including symptom burden as research tool throughout the trajectory of cancer survivorship...
Prognostic value of symptom burden for overall survival in patients receiving chemotherapy for advanced nonsmall cell lung cancerXin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Cancer 116:137-45. 2010..However, translating patient-reported outcomes into useful prognostic information for individual patients has been problematic...
Cancer pain management among underserved minority outpatients: perceived needs and barriers to optimal controlKaren O Anderson
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 94:2295-304. 2002..Structured interviews allowed the authors to probe for previously unidentified barriers to pain management in these populations...
Pain and quality of life after treatment in patients with locally recurrent rectal cancerNestor F Esnaola
Department of Surgery, Pain Research Group, The University of Texas M D Anderson Cancer Center, Houston 77030 4009, USA
J Clin Oncol 20:4361-7. 2002..The purpose of this study was to assess the prevalence of posttreatment pain and QOL of patients with LRRC treated with nonsurgical palliation or resection and identify predictors of poor outcome...
Lessons learned from a multiple-dose post-operative analgesic trialTito R Mendoza
Pain Research Group, Department of Symptom Research, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Box 221, Houston, TX 77030, USA
Pain 109:103-9. 2004....
Fatigue and sleep disturbance in patients with cancer, patients with clinical depression, and community-dwelling adultsKaren O Anderson
Department of Symptom Research, Division of Anesthesiology and Critical Care, The University of Texas M. D. Anderson Cancer Center, 1100 Holcombe Boulevard, Box 221, Houston, TX 77030, USA
J Pain Symptom Manage 25:307-18. 2003..Although the majority of the psychiatric patients reported sleep disturbance, their sleep disturbance scores were not significantly associated with fatigue severity...
Measuring the symptom burden of lung cancer: the validity and utility of the lung cancer module of the M. D. Anderson Symptom InventoryTito R Mendoza
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 1450, Houston, Texas 77030, USA
Oncologist 16:217-27. 2011....
Pain and fatigue in community-dwelling adultsCielito C Reyes-Gibby
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Pain Med 4:231-7. 2003..We also assessed the prevalence of mild, moderate, and severe fatigue for this sample...
Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapyLajos Pusztai
Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
Cytokine 25:94-102. 2004..The objective of this study was to assess changes in plasma levels of interleukin (IL)-1beta, IL-6, IL-8, IL-10, IL-12, and TNF-alpha during chemotherapy and to correlate these changes with musculoskeletal symptoms...
Assessment of fatigue in cancer patients and community dwellers: validation study of the Filipino version of the brief fatigue inventoryTito R Mendoza
Department of Symptom Research, Division of Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, Tex 77030, USA
Oncology 79:112-7. 2010..We developed and validated a Filipino language version of the Brief Fatigue Inventory (BFI-F) for describing the prevalence and severity of fatigue among Filipino patients with cancer...
Caregiver symptom burden: the risk of caring for an underserved patient with advanced cancerGuadalupe R Palos
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 117:1070-9. 2011..In this longitudinal study, the authors assessed changes in symptom severity in caregivers and underserved minority patients diagnosed with advanced solid tumors who were being treated at public hospitals...
Biological pathways and genetic variables involved in painQiuling Shi
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1450, Houston, TX 77030, USA
Qual Life Res 19:1407-17. 2010..This paper summarizes current knowledge of pain-related and analgesic-related pathways as well as genetic variations involved in pain perception and management...
Does recall period have an effect on cancer patients' ratings of the severity of multiple symptoms?Qiuling Shi
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 40:191-9. 2010..Choosing an appropriate recall period for symptom assessment in a clinical trial is dependent on the design and purpose of the trial...
Inflammatory cytokines are associated with the development of symptom burden in patients with NSCLC undergoing concurrent chemoradiation therapyXin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
Brain Behav Immun 24:968-74. 2010....
The utility and validity of the modified brief pain inventory in a multiple-dose postoperative analgesic trialTito R Mendoza
Pain Research Group, Department of Symptom Research, University of Texas MD Anderson Cancer Center, Houston 77030, USA
Clin J Pain 20:357-62. 2004..Our objective was to validate use of the modified Brief Pain Inventory through reanalysis of pain data from a multiple-dose, placebo-controlled, randomized trial of analgesia after coronary artery bypass graft surgery...
Chinese version of the M. D. Anderson Symptom Inventory: validation and application of symptom measurement in cancer patientsXin Shelley Wang
Division of Internal Medicine, Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 101:1890-901. 2004..Because disease-related and treatment-related symptoms most often occur in clusters, there is a global need for a standardized multiple-symptom assessment tool...
Impact of cultural and linguistic factors on symptom reporting by patients with cancerXin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Unit 1450, Houston, TX 77030, USA
J Natl Cancer Inst 102:732-8. 2010..In multinational clinical trials, cultural and linguistic variations in patient-reported outcomes instruments could confound the interpretation of study results...
Validation and application of a module of the M. D. Anderson Symptom Inventory for measuring multiple symptoms in patients with gastrointestinal cancer (the MDASI-GI)Xin Shelley Wang
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
Cancer 116:2053-63. 2010..The authors report the development of an MDASI module for use in patients with gastrointestinal (GI) cancer (the MDASI-GI)...
Pain education for underserved minority cancer patients: a randomized controlled trialKaren O Anderson
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, 1100 Holcombe Blvd, Box 221, Houston, TX 77030, USA
J Clin Oncol 22:4918-25. 2004..Previous studies found that African American and Hispanic cancer patients are at risk for undertreatment of pain. We evaluated the efficacy of a pain education intervention for underserved minority patients...
Clinical factors associated with cancer-related fatigue in patients being treated for leukemia and non-Hodgkin's lymphomaXin Shelley Wang
Department of Symptom Research, Division of Anesthesiology and Critical Care, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Clin Oncol 20:1319-28. 2002..To describe fatigue severity, fatigue interference, and associated factors in hematologic malignancies...
Psychometric testing of the MDASI-HF: a symptom assessment instrument for patients with cancer and concurrent heart failureAnecita Fadol
Department of Cardiology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Card Fail 14:497-507. 2008..This study evaluated the psychometric properties of the MD Anderson Symptom Inventory--Heart Failure (MDASI-HF), a 27-item self-report assessment instrument for patients with cancer and concurrent HF...
Pediatric cancer pain management practices and attitudes in ChinaXin Shelley Wang
Department of Symptom Research, Division of Anesthesiology and Critical Care, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 26:748-59. 2003..10, CI=1.31-3.37), and belief that children are less sensitive to pain (OR=1.96, CI=1.02-3.76). The top barriers to optimal pediatric pain management were identified as fear of opioid addiction and inadequate knowledge of pain management...
Japanese version of the MD Anderson Symptom Inventory: a validation studyToru Okuyama
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
J Pain Symptom Manage 26:1093-104. 2003..Both factor analysis and cluster analysis showed the consistency of the statistical structure of the English and Japanese versions, indicating the cross-cultural validity of the scale...
A preliminary study of the utility of the brief hospice inventoryH Guo
Pain Research Group, The University of Texas M. D. Anderson Cancer Center, 1100 Holcombe Blvd. Houston, TX 77030, USA
J Pain Symptom Manage 22:637-48. 2001..The BHI shows utility in measuring hospice patients' symptom severity and quality of life over time...
Variations in patients' self-report of pain by treatment settingCielito C Reyes-Gibby
Pain Research Group, Department of Symptom Research, University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
J Pain Symptom Manage 25:444-8. 2003....
Validation study of the Japanese version of the brief fatigue inventoryToru Okuyama
Pain Research Group, Division of Anesthesiology and Critical Care, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA
J Pain Symptom Manage 25:106-17. 2003..Additionally, fatigue severity classification was explored using the BFI-J. The results indicated that the BFI-J is a brief, valid, and feasible measure of fatigue for use with Japanese cancer patients...
Assessing the Symptoms of Cancer Using Patient-Reported Outcomes (ASCPRO): searching for standardsCharles S Cleeland
Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
J Pain Symptom Manage 39:1077-85. 2010....
Clinical utility of the MDASI-BT in patients with brain metastasesTerri S Armstrong
Department of Integrative Nursing Care, The University of Texas Health Science Center School of Nursing, Houston, Texas 77030, USA
J Pain Symptom Manage 37:331-40. 2009..The MDASI-BT demonstrated validity and reliability in brain metastases patients and can be used to identify and monitor symptom occurrence in relation to treatment course and survival...
Perceptions of analgesic use and side effects: what the public values in pain managementGuadalupe R Palos
Department of Symptom Research, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030-4009, USA
J Pain Symptom Manage 28:460-73. 2004..To achieve better pain outcomes, clinicians and patients must identify factors that contribute to conservative decision-making about analgesic use and side effect management...
The role of statins in cancer therapyKatja Hindler
Division of Cardiovascular Anesthesiology, The Texas Heart Institute at St. Luke's Episcopal Hospital, 6720 Bertner Avenue, Houston, Texas 77030, USA
Oncologist 11:306-15. 2006..The feasibility and efficacy of statins for the prevention and treatment of cancer is reviewed...
Assessment of cancer-related neuropathy and neuropathic painCharles S Cleeland
University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Oncologist 15:13-8. 2010....
A cytokine-based neuroimmunologic mechanism of cancer-related symptomsBang-Ning Lee
Department of Hematopathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
Neuroimmunomodulation 11:279-92. 2004..These concepts open exciting new avenues for translational research in the pathophysiology and treatment of cancer-related symptoms...
Development and initial validation of the thyroid cancer module of the M. D. Anderson Symptom InventoryIbrahima Gning
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, Tex 77030, USA
Oncology 76:59-68. 2009..The M. D. Anderson Symptom Inventory (MDASI) and its modules measure common symptoms related to cancer and its treatment. We report the development and initial validation of the MDASI-Thyroid Cancer module (MDASI-THY)...
People in pain: how do they seek relief?Qiuling Shi
Department of Symptom Research, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
J Pain 8:624-36. 2007..Difficulty communicating with health professionals and lack of health insurance contributed to inadequate pain relief. Almost all people with pain used multiple methods to control their pain...
Patient training in cancer pain management using integrated print and video materials: a multisite randomized controlled trialKaren L Syrjala
Biobehavioral Sciences, Clinical Research Division, Fred Hutchinson Cancer Research Center, D5 220, 1100 Fairview Avenue N, Seattle, WA 98109, USA
Pain 135:175-86. 2008..Using video and print materials, with brief individualized training, effectively improved pain management over time for cancer patients of varying diagnostic and demographic groups...
Validity of the brief pain inventory for use in documenting the outcomes of patients with noncancer painSan Keller
American Institutes for Research, Chapel Hill, NC 27514 2825, USA
Clin J Pain 20:309-18. 2004..The current research addresses the need for formal evaluation of the reliability and validity of the BPI for use in non-cancer pain patients...
Assessing symptom burden using the M. D. Anderson symptom inventory in patients with chemotherapy-induced anemia: results of a multicenter, open-label study (SURPASS) of patients treated with darbepoetin-alpha at a dose of 200 microg every 2 weeksJanice L Gabrilove
Division of Hematology Oncology, Mount Sinai Medical Center, New York, New York, USA
Cancer 110:1629-40. 2007....
Identifying important outcome domains for chronic pain clinical trials: an IMMPACT survey of people with painDennis C Turk
Department of Anesthesiology, University of Washington, Seattle, WA 98195, USA
Pain 137:276-85. 2008..These multiple outcomes should be considered when evaluating the efficacy and effectiveness of chronic pain treatments...
The analgesic effects that underlie patient satisfaction with treatmentMark P Jensen
Department of Rehabilitation Medicine, School of Medicine, University of Washington, Seattle 98195 6490, USA
Pain 110:480-7. 2004..g. decreased pain, opioid-related symptoms) mediated, in part, the effects of treatment on treatment satisfaction...
Taiwanese version of the M. D. Anderson symptom inventory: symptom assessment in cancer patientsChia Chin Lin
Graduate Institute of Nursing, Taipei Medical University, Tainan, Taiwan
J Pain Symptom Manage 33:180-8. 2007..The MDASI-T is a reliable, valid, and sensitive instrument for measuring the severity and interference with daily life of cancer-related symptoms among Taiwanese cancer patients...
Management of cancer painAllen W Burton
JAMA 291:1067-8; author reply 1068-9. 2004
Long-term use of controlled-release oxycodone for noncancer pain: results of a 3-year registry studyRussell K Portenoy
Department of Pain Medicine and Palliative Care, Beth Israel Medical Center, New York, NY 10003, USA
Clin J Pain 23:287-99. 2007..To evaluate the outcomes associated with the use of controlled-release (CR) oxycodone for up to 3 years in the treatment of noncancer pain...
[Validation of the Spanish version of the Brief Pain Inventory in patients with oncological pain]Xavier Badia
Unitat de Recerca en Resultats en Salut, Servei d Epidemiologia Clínica i Salut Pública, Hospital de la Santa Creu i Sant Pau, Barcelona, Espana
Med Clin (Barc) 120:52-9. 2003..Our goal was to validate the Spanish version of the Brief Pain Inventory (BPI) questionnaire used to measure the intensity of oncological pain and its impact on activities of daily living in patients with cancer...
The Norwegian brief pain inventory questionnaire: translation and validation in cancer pain patientsPål Klepstad
Department of Anesthesiology and Medical Imaging, Norwegian University of Science and Technology, Trondheim, Norway
J Pain Symptom Manage 24:517-25. 2002....
Assessment of clinical relevant fatigue level in cancerYoon Jung Chang
Research Institute for National Cancer Control and Evaluation, National Cancer Center, Goyang, Gyeonggi, South Korea
Support Care Cancer 15:891-6. 2007....
Development of a cancer pain assessment tool in Korea: a validation study of a Korean version of the brief pain inventoryYoung Ho Yun
Research Institute and Hospital, National Cancer Center, Goyang, Korea
Oncology 66:439-44. 2004..Seventy-four percent of the patients in the Seoul sample had inadequate analgesia using the PMI. CONCLUSION: The BPI-K is a valid and useful instrument for assessing cancer pain and pain impact in Korea...
Russian Brief Pain Inventory: validation and application in cancer painSvetlana A Kalyadina
National Cancer Research and Treatment Center, St Petersburg, Russia
J Pain Symptom Manage 35:95-102. 2008..Having advanced-stage disease and not receiving chemotherapy predicted inadequate pain management in a multivariate logistic regression model. The Russian version of the BPI is psychometrically sound in its reliability and validity...
Fatigue in the general Korean population: application and normative data of the Brief Fatigue InventoryYoung Ho Yun
Division of Cancer Control, National Cancer Control Research Institute, National Cancer Center, Goyang, Gyeonggi, Korea
J Pain Symptom Manage 36:259-67. 2008..Our findings indicate that comorbidities should be considered when comparing fatigue data from the general population with data from patients...
Assessing cancer symptoms in adolescents with cancer using the Taiwanese version of the M. D. Anderson Symptom InventoryTsui Hwa Tseng
Graduate Institute of Medical Sciences, Taipei Medical University, Taipei, Taiwan
Cancer Nurs 31:E9-16. 2008..This study provides evidence that the MDASI-T is a reliable and valid instrument for measuring cancer-related symptoms in Taiwanese adolescents with cancer...
Clinicians' practice and attitudes toward cancer pain management in KoreaYeon Soo Jeon
Department of Anesthesiology and Pain Medicine, Saint Vincent s Hospital, The Catholic University of Korea, 93 6 Chi Dong, Paldal Gu, Suwon, South Korea
Support Care Cancer 15:463-9. 2007..The purposes of this study were to assess clinicians' (n = 250) current practices and attitudes about cancer pain management and to identify perceived concerns about and barriers to pain control in urban cancer-treatment settings in Korea...
Validation of the Taiwanese version of the Brief Fatigue InventoryChia Chin Lin
Graduate Institute of Nursing, Taipei Medical University, Taipei, Taiwan, ROC
J Pain Symptom Manage 32:52-9. 2006..The BFI-T is reliable, valid, and sensitive for measuring cancer-related fatigue severity and interference among Taiwanese cancer patients...
Validation study of the Korean version of the M. D. Anderson Symptom InventoryYoung Ho Yun
Quality of Cancer Care Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
J Pain Symptom Manage 31:345-52. 2006..The MDASI-K is a valid and reliable measure for assessing multiple symptoms in Korean cancer patients...
Pain and suffering during cancer therapy: continued sins of omissionNora A Janjan
Int J Radiat Oncol Biol Phys 72:6-8. 2008
Patient-reported outcomes: instrument development and selection issuesRalph R Turner
Phase V Technologies Inc, Wellesley Hills, MA, USA
Value Health 10:S86-93. 2007..Finally, PRO assessment is meaningless if the key figure chooses not to cooperate. We consider how respondent burden influences the quality of PRO assessment...
Cancer-related symptom assessment in Russia: validation and utility of the Russian M. D. Anderson Symptom InventoryMaria O Ivanova
National Cancer Research and Treatment Center, St. Petersburg, Russia
J Pain Symptom Manage 30:443-53. 2005..Medical professionals underestimated the severity of pain, fatigue, and distress. The MDASI-R is valid and reliable for measuring symptom severity and interference in Russian cancer patients...
Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastasesWilliam F Hartsell
Advocate Good Samaritan Hospital, Downers Grove, IL, USA
J Natl Cancer Inst 97:798-804. 2005..We investigated whether 8 Gy delivered in a single treatment fraction provides pain and narcotic relief that is equivalent to that of the standard treatment course of 30 Gy delivered in 10 treatment fractions over 2 weeks...
Validation study of the korean version of the brief fatigue inventoryYoung Ho Yun
Quality of Cancer Care Branch, Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
J Pain Symptom Manage 29:165-72. 2005..Our study has shown that the BFI-K is a reliable, valid self-rating instrument in terms of its psychometric properties...
Symptoms in the lives of terminal cancer patients: which is the most important?Yong Chol Kwon
Research Institute and Hospital, National Cancer Center, Goyang, Gyeonggi, Korea
Oncology 71:69-76. 2006..Symptoms other than their primary disease can interfere in the lives of terminal cancer patients. We sought to identify which of these symptoms is most important...
Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendationsRobert H Dworkin
Department of Anesthesiology, University of Rochester School of Medicine and Dentistry, Rochester, New York 14642, USA
J Pain 9:105-21. 2008....
Advances in treating metastatic bone cancer: summary statement for the First Cambridge ConferenceAllan Lipton
Milton S Hershey Medical Center, Penn State University College of Medicine, Hershey, Pennsylvania 17033 0850, USA, and Department of Oncology, Norwegian Radium Hospital, Oslo, Norway
Clin Cancer Res 12:6209s-6212s. 2006..The conclusions reached during the 2-day meeting are summarized in this article and presented in more detail in the individual articles and accompanying discussion sessions that comprise the conference proceedings...
Health-related quality of life and symptom assessment in clinical research of patients with hematologic malignancies: where are we now and where do we go from here?Fabio Efficace
Haematologica 92:1596-8. 2007
Research Grants
- Pain and Symptoms of Cancer: Assessment and TreatmentCharles Cleeland; Fiscal Year: 2007....
- Understanding the Impact of Multiple Symptoms: A Symptom Burden ConsortiumCharles Cleeland; Fiscal Year: 2006..The document will be a collaborative effort among consortium participants, and will be submitted to a leading scientific peer-reviewed journal. ..
- Reducing the Symptom Burden Produced by Aggressive Cancer TherapiesCharles Cleeland; Fiscal Year: 2009..The ultimate goal of this research is to be able to administer the best available curative therapy to the largest number of patients with the least treatment-related symptom burden. ..
- Mechanisms and Treatment of Cancer-Related Symptoms ConfCharles Cleeland; Fiscal Year: 2005..The conference should also be of interest to pharmaceutical companies that are developing "pipeline" drugs for symptom control and supportive care. ..
- CANCER PAIN AND ITS MANAGEMENTCharles Cleeland; Fiscal Year: 2001....
- Reducing the Symptom Burden Produced by Aggressive Cancer TherapiesCharles S Cleeland; Fiscal Year: 2010..The ultimate goal of this research is to be able to administer the best available curative therapy to the largest number of patients with the least treatment-related symptom burden. ..
